Search VHI
VALHI INC /DE/
NYSE · CIK 59255
Last close14.89
Daily change-0.32 (-2.10%)
10 Years gain+108.48%
Dividends TTM0.32 (+0.00%)
Dividend yield2.10%
Fundamental Analysis
VHI · STANDARD
SIC 2810 · Industrial Inorganic Chemicals · Fiscal year end 1231
Fundamental
23.3Momentum
35.5Acceleration
35.5Confidence
77.0Annual Revenue17
Quarterly Revenue73
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.6 / 25
Quality5.9 / 25
Capital Efficiency8.3 / 20
Balance Sheet8.5 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 4.2725 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 2.8909 percentage points.
Low interest coverage · HIGHInterest coverage is 2.4905x.
Key Metrics
Revenue Growth TTM2.2%OK
Revenue CAGR 3Y-2.23%OK
Gross Margin16.37%OK
Operating Margin6.55%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC11.08%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y0%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $2.08B | $295.40M | $63.30M | -$35.50M | -$82.10M | 14.22% | 3.05% | -3.95% | 6.7% | 28.5 |
| 2025 FY Dec 31, 2024 | $2.10B | $424.50M | $210.70M | $44.00M | $13.10M | 20.17% | 10.01% | 0.62% | 23.72% | 28.5 |
| 2025 FY Dec 31, 2023 | $1.92B | $245.20M | $34.20M | $3.90M | -$44.60M | 12.76% | 1.78% | -2.32% | 6.06% | 28.5 |
| 2024 FY Dec 31, 2022 | $2.22B | $490.40M | $239.40M | $34.90M | -$32.70M | 22.07% | 10.77% | -1.47% | 70.31% | 28.5 |
| 2023 FY Dec 31, 2021 | $2.30B | $580.20M | $318.60M | $459.70M | $395.60M | 25.27% | 13.87% | 17.23% | 169.67% | 28.5M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $2.21B | sum latest 4 fiscal quarters Revenue | OK | 0001104659-26-092027, 0001104659-25-107777 |
| Revenue Growth TTM | 2.2% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001104659-26-092027, 0001104659-25-107777 |
| Revenue CAGR 3Y | -2.23% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-025847 |
| Revenue CAGR 5Y | 2.35% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001104659-26-025847 |
| Gross Profit CAGR 3Y | -15.55% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-025847 |
| Operating Income Growth | -29.1% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001104659-26-092027, 0001104659-25-107777 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 16.37% | Gross Profit / Revenue | OK | 0001104659-26-092027, 0001104659-25-107777 |
| Operating Margin | 6.55% | Operating Income / Revenue | OK | 0001104659-26-092027, 0001104659-25-107777 |
| ROIC | 11.08% | NOPAT / Average Invested Capital | OK | 0001104659-26-092027, 0001104659-25-107777 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001104659-26-092027 |
| Interest Coverage | 2.49x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 3.37x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $77.55 | Revenue / Diluted Shares | OK | 0001104659-26-092027, 0001104659-25-107777 |